Public Perception On COVID-19 Vaccination Intention

Zaid zaid

Abstract


In order to resolve the health crisis caused by COVID-19, the Indonesian government is trying to implement a mandatory vaccination policy for all Indonesians. It was just that the success of this policy is largely determined by acceptance preceded by the public intention to be vaccinated in which public perception plays a major role in determining intention. This research, therefore, aimed to evaluate and examine the role of perceived risk, benefit, and susceptibility on the COVID-19 vaccination intention. By using a cross-sectional approach, this quantitative study involved 98 participating respondents who were determined by the purposive sampling method. The results of this study finally found and proven that perceived risk (coefficient β = 0.290 and T-value 2.456 with ρ-value = 0.011), perceived benefits (β = 0.394 and T-value 3.873 with ρ-value = 0.000), and perceived susceptibility (β = 0.233 and T-value 3,230 with ρ-value = 0.001) had a positive and significant effect on the Covid-19 vaccination intention.

References


F. B. Muhib, C. J. Pecenka, and A. A. Marfin, “Risk-based Vaccines and the Need for Risk-based Subnational Vaccination Strategies for Introduction,” Clin. Infect. Dis., vol. 71, no. Supplement_2, pp. S165–S171, Jul. 2020, doi: 10.1093/cid/ciaa483.

D. Jolley and K. M. Douglas, “The effects of anti-vaccine conspiracy theories on vaccination intentions,” PLoS One, vol. 9, no. 2, p. e89177, Feb. 2014, doi: 10.1371/journal.pone.0089177.

M. Vrdelja, V. Učakar, and A. Kraigher, “From mandatory to voluntary vaccination: intention to vaccinate in the case of policy changes,” Public Health, vol. 180, pp. 57–63, Mar. 2020, doi: 10.1016/j.puhe.2019.10.026.

E. Jaffe, A. D. Lyerly, and I. T. Goldfarb, “Pregnant women’s perceptions of risks and benefits when considering participation in vaccine trials,” Vaccine, vol. 38, no. 44, pp. 6922–6929, Oct. 2020, doi: 10.1016/j.vaccine.2020.08.059.

B. S. Hooker and N. Z. Miller, “Analysis of health outcomes in vaccinated and unvaccinated children: Developmental delays, asthma, ear infections and gastrointestinal disorders,” SAGE Open Med., vol. 8, p. 205031212092534, Jan. 2020, doi: 10.1177/2050312120925344.

L. O. Gostin, S. A. Karim, and B. Mason Meier, “Facilitating Access to a COVID-19 Vaccine through Global Health Law,” J. Law, Med. Ethics, vol. 48, no. 3, pp. 622–626, Sep. 2020, doi: 10.1177/1073110520958892.

C. A. Gidengil, A. M. Parker, and B. J. Zikmund-Fisher, “Trends in risk perceptions and vaccination intentions: A longitudinal study of the first year of the H1N1 pandemic,” Am. J. Public Health, vol. 102, no. 4, pp. 672–679, Apr. 2012, doi: 10.2105/AJPH.2011.300407.

D. Maciorowski, C. Ogaugwu, S. R. Durvasula, R. Durvasula, and A. Kunamneni, “Therapeutic and Vaccine Options for COVID-19: Status after 6 Months of the Disease Outbreak,” SLAS Discovery. p. 247255522097957, Dec. 15, 2020, doi: 10.1177/2472555220979579.

P. Peretti-Watel et al., “A future vaccination campaign against COVID-19 at risk of vaccine hesitancy and politicisation,” Lancet Infect. Dis., vol. 20, no. 7, pp. 769–770, Jul. 2020, doi: 10.1016/S1473-3099(20)30426-6.

J. McAteer, I. Yildirim, and A. Chahroudi, “The VACCINES act: Deciphering vaccine hesitancy in the time of COVID-19,” Clinical Infectious Diseases, vol. 71, no. 15. pp. 703–705, Jul. 28, 2020, doi: 10.1093/cid/ciaa433.

I. Ajzen, “The theory of planned behavior,” Organ. Behav. Hum. Decis. Process., vol. 50, no. 2, pp. 179–211, 1991, doi: 10.1016/0749-5978(91)90020-T.

J. Bryer, “Black Parents’ Beliefs, Attitudes, and HPV Vaccine Intentions,” Clin. Nurs. Res., vol. 23, no. 4, pp. 369–383, Aug. 2014, doi: 10.1177/1054773813487749.

L. Ou and S. D. Youngstedt, “The Role of Vaccination Interventions to Promote HPV Vaccine Uptake Rates in a College-Aged Population: a Systematic Review,” J. Cancer Educ., 2020, doi: 10.1007/s13187-020-01806-1.

M. P. Nowalk et al., “Influenza Vaccine Intention After a Medically Attended Acute Respiratory Infection,” Health Promot. Pract., vol. 20, no. 4, pp. 539–552, 2019, doi: 10.1177/1524839918782137.

E. Karafillakis and H. J. Larson, “The benefit of the doubt or doubts over benefits? A systematic literature review of perceived risks of vaccines in European populations,” Vaccine, vol. 35, no. 37. Elsevier Ltd, pp. 4840–4850, 2017, doi: 10.1016/j.vaccine.2017.07.061.

Z. J. Yang, “Predicting young adults intentions to get the H1N1 vaccine: An integrated model,” J. Health Commun., vol. 20, no. 1, pp. 69–79, 2015, doi: 10.1080/10810730.2014.904023.

T. Nadarzynski, H. Smith, D. Richardson, C. J. Jones, and C. D. Llewellyn, “Human papillomavirus and vaccine-related perceptions among men who have sex with men: A systematic review,” Sex. Transm. Infect., vol. 90, no. 7, pp. 515–523, 2014, doi: 10.1136/sextrans-2013-051357.

M. Jones and R. Cook, “Intent to receive an HPV vaccine among university men and women and implications for vaccine administration,” J. Am. Coll. Heal., vol. 57, no. 1, pp. 23–32, 2008, doi: 10.3200/JACH.57.1.23-32.

B. Baumgaertner, J. E. Carlisle, and F. Justwan, “The influence of political ideology and trust on willingness to vaccinate,” PLoS One, vol. 13, no. 1, p. e0191728, 2018, doi: 10.1371/journal.pone.0191728.

A. E. Leader, J. L. Weiner, B. J. Kelly, R. C. Hornik, and J. N. Cappella, “Effects of information framing on human papillomavirus vaccination,” J. Women’s Heal., vol. 18, no. 2, pp. 225–233, 2009, doi: 10.1089/jwh.2007.0711.

J. Lechuga, G. R. Swain, and L. S. Weinhardt, “Impact of framing on intentions to vaccinate daughters against HPV: A cross-cultural perspective,” Ann. Behav. Med., vol. 42, no. 2, pp. 221–226, 2011, doi: 10.1007/s12160-011-9273-1.

P. Slovic, M. L. Finucane, E. Peters, and D. G. MacGregor, “Risk as Analysis and Risk as Feelings: Some Thoughts about Affect, Reason, Risk, and Rationality,” Risk Anal., vol. 24, no. 2, pp. 311–322, 2004, doi: 10.1111/j.0272-4332.2004.00433.x.

E. Dubé, C. Laberge, M. Guay, P. Bramadat, R. Roy, and J. Bettinger, “Vaccine hesitancy: An overview,” Hum. Vaccines Immunother., vol. 9, no. 8, pp. 1763–1773, 2013, doi: 10.4161/hv.24657.

R. Schmälzle, B. Renner, and H. T. Schupp, “Health Risk Perception and Risk Communication,” Policy Insights from the Behavioral and Brain Sciences, vol. 4, no. 2. SAGE Publications Ltd, pp. 163–169, 2017, doi: 10.1177/2372732217720223.

Y. Hanoch, J. J. Rolison, and A. M. Freund, “Does Medical Risk Perception and Risk Taking Change with Age?,” Risk Anal., vol. 38, no. 5, pp. 917–928, 2018, doi: 10.1111/risa.12692.

L. Bond and T. Nolan, “Making sense of perceptions of risk of diseases and vaccinations: a qualitative study combining models of health beliefs, decision-making and risk perception,” BMC Public Health, vol. 11, no. 1, p. 943, 2011, doi: 10.1186/1471-2458-11-943.

L. C. Karlsson et al., “Fearing the disease or the vaccine: The case of COVID-19,” Pers. Individ. Dif., vol. 172, p. 110590, 2021, doi: 10.1016/j.paid.2020.110590.

K. J. Petrie, K. Faasse, and M. G. Thomas, “Public Perceptions and Knowledge of the Ebola Virus, Willingness to Vaccinate, and Likely Behavioral Responses to an Outbreak,” Disaster Med. Public Health Prep., vol. 10, no. 4, pp. 674–680, 2016, doi: 10.1017/dmp.2016.67.

K. Faasse and J. Newby, “Public Perceptions of COVID-19 in Australia: Perceived Risk, Knowledge, Health-Protective Behaviors, and Vaccine Intentions,” Front. Psychol., vol. 11, 2020, doi: 10.3389/fpsyg.2020.551004.

J. Zhang, A. E. While, and I. J. Norman, “Seasonal influenza vaccination knowledge, risk perception, health beliefs and vaccination behaviours of nurses,” Epidemiol. Infect., vol. 140, no. 9, pp. 1569–1577, 2012, doi: 10.1017/S0950268811002214.

L. Doornekamp, L. van Leeuwen, E. van Gorp, H. Voeten, and M. Goeijenbier, “Determinants of Vaccination Uptake in Risk Populations: A Comprehensive Literature Review,” Vaccines, vol. 8, no. 3, p. 480, 2020, doi: 10.3390/vaccines8030480.

K. L. Ratnapradipa, R. Norrenberns, J. A. Turner, and A. Kunerth, “Freshman Flu Vaccination Behavior and Intention During a Nonpandemic Season,” Health Promot. Pract., vol. 18, no. 5, pp. 662–671, Sep. 2017, doi: 10.1177/1524839917712731.

L. P. Wong, H. Alias, P. F. Wong, H. Y. Lee, and S. AbuBakar, “The use of the health belief model to assess predictors of intent to receive the COVID-19 vaccine and willingness to pay,” Hum. Vaccines Immunother., vol. 16, no. 9, pp. 2204–2214, 2020, doi: 10.1080/21645515.2020.1790279.

L. B. Myers and R. Goodwin, “Determinants of adults’ intention to vaccinate against pandemic swine flu,” BMC Public Health, vol. 11, no. 1, p. 15, 2011, doi: 10.1186/1471-2458-11-15.

S. Mehrolia, S. Alagarsamy, and J. S, “Assessing perceptions of COVID-19 self-protective measures: a structural equation modeling (SEM) approach,” J. Heal. Res., vol. ahead-of-print, no. ahead-of-print, 2021, doi: 10.1108/JHR-07-2020-0244.

E. L. Thompson, A. Garg, A. M. Galvin, J. D. Moore, M. L. Kasting, and C. W. Wheldon, “Correlates of HPV Vaccination Intentions Among Adults Ages 27–45 Years Old in the U.S.,” J. Community Health, pp. 1–10, 2021, doi: 10.1007/s10900-021-00968-3.

J. T. F. Lau, Z. Wang, J. H. Kim, M. Lau, C. H. Y. Lai, and P. K. H. Mo, “Acceptability of HPV Vaccines and Associations with Perceptions Related to HPV and HPV Vaccines Among Men Who Have Sex with Men in Hong Kong,” PLoS One, vol. 8, no. 2, p. e57204, 2013, doi: 10.1371/journal.pone.0057204.

A. Chan, B. Brown, E. Sepulveda, and L. Teran-Clayton, “Evaluation of fotonovela to increase human papillomavirus vaccine knowledge, attitudes, and intentions in a low-income Hispanic community,” BMC Res. Notes, vol. 8, no. 1, p. 615, 2015, doi: 10.1186/s13104-015-1609-7.

N. T. Nancy Chen, “Predicting Vaccination Intention and Benefit and Risk Perceptions: The Incorporation of Affect, Trust, and Television Influence in a Dual-Mode Model,” Risk Anal., vol. 35, no. 7, pp. 1268–1280, 2015, doi: 10.1111/risa.12348.

E. P. Armitage et al., “Acceptability of intranasal live attenuated influenza vaccine, influenza knowledge and vaccine intent in The Gambia,” Vaccine, vol. 36, no. 13, pp. 1772–1780, 2018, doi: 10.1016/j.vaccine.2018.02.037.

M. Setbon and J. Raude, “Factors in vaccination intention against the pandemic influenza A/H1N1,” Eur. J. Public Health, vol. 20, no. 5, pp. 490–494, 2010, doi: 10.1093/eurpub/ckq054.

A. L. Krawczyk et al., “Human papillomavirus vaccination intentions and uptake in college women,” Heal. Psychol., vol. 31, no. 5, pp. 685–693, 2012, doi: 10.1037/a0027012.

V. L. Sanders Thompson, L. D. Arnold, and S. R. Notaro, “African American parents’ HPV vaccination intent and concerns,” J. Health Care Poor Underserved, vol. 23, no. 1, pp. 290–301, 2012, doi: 10.1353/hpu.2012.0007.

J. Z. Yang and M. M. Pittman, “The Silver Lining of Shame: Framing HPV to Influence Vaccination Intentions,” Health Commun., vol. 32, no. 8, pp. 987–994, 2017, doi: 10.1080/10410236.2016.1196420.

M. Stafford, S. Prabhu, S. A. Egea, M. D. C. G. Gonzalez, and A. K. Shetty, “Knowledge and attitudes about zika virus infection and vaccine intent among medical students in Costa Rica,” Am. J. Trop. Med. Hyg., vol. 103, no. 6, pp. 2453–2459, 2020, doi: 10.4269/ajtmh.19-0748.

C. Liu, S. Nicholas, and J. Wang, “The association between protection motivation and hepatitis b vaccination intention among migrant workers in Tianjin, China: A cross-sectional study,” BMC Public Health, vol. 20, no. 1, p. 1219, 2020, doi: 10.1186/s12889-020-09292-2.

K. J. Head, M. L. Kasting, L. A. Sturm, J. A. Hartsock, and G. D. Zimet, “A National Survey Assessing SARS-CoV-2 Vaccination Intentions: Implications for Future Public Health Communication Efforts,” Sci. Commun., vol. 42, no. 5, pp. 698–723, 2020, doi: 10.1177/1075547020960463.

Y. Yu, J. T. F. Lau, M. M. C. Lau, M. C. S. Wong, and P. K. S. Chan, “Understanding the Prevalence and Associated Factors of Behavioral Intention of COVID-19 Vaccination Under Specific Scenarios Combining Effectiveness, Safety, and Cost in the Hong Kong Chinese General Population,” Int. J. Heal. Policy Manag., vol. 2021, pp. 1–12, 2021, doi: 10.34172/ijhpm.2021.02.

C. Lagoe and K. M. Farrar, “Are you willing to risk it? The relationship between risk, regret, and vaccination intent,” Psychol. Heal. Med., vol. 20, no. 1, pp. 18–24, 2015, doi: 10.1080/13548506.2014.911923.

D. Iacobucci, “Structural equations modeling: Fit Indices, sample size, and advanced topics,” J. Consum. Psychol., vol. 20, no. 1, pp. 90–98, 2010, doi: 10.1016/j.jcps.2009.09.003.

E. J. Wolf, K. M. Harrington, S. L. Clark, and M. W. Miller, “Sample Size Requirements for Structural Equation Models: An Evaluation of Power, Bias, and Solution Propriety,” Educ. Psychol. Meas., vol. 73, no. 6, pp. 913–934, Dec. 2013, doi: 10.1177/0013164413495237.

R. J. Harris, A primer of multivariate statistics. New York: Academic Press, 1975.

R. F. Falk and N. B. Miller, A Primer for Soft Modeling, 1st ed. Ohio: University of Akron Press, 1992.

R. Weston and P. A. Gore, “A Brief Guide to Structural Equation Modeling,” Couns. Psychol., vol. 34, no. 5, pp. 719–751, Sep. 2006, doi: 10.1177/0011000006286345.

J. F. Hair, M. Sarstedt, L. Hopkins, and V. G. Kuppelwieser, “Partial least squares structural equation modeling (PLS-SEM): An emerging tool in business research,” European Business Review, vol. 26, no. 2. Emerald Group Publishing Ltd., pp. 106–121, Mar. 04, 2014, doi: 10.1108/EBR-10-2013-0128.

M. Sarstedt, C. M. Ringle, and J. F. Hair, “Partial Least Squares Structural Equation Modeling,” in Handbook of Market Research, Cham: Springer International Publishing, 2017, pp. 1–40.

M. Mehmetoglu, “Partial least squares approach to structural equation modeling for tourism research,” Adv. Hosp. Leis., vol. 8, pp. 43–61, 2012, doi: 10.1108/S1745-3542(2012)0000008007.

I. Ghozali, “Structural EquationModeling, Metode Alternatif dengan Partial Least Square (PLS),” Semarang: Badan Penerbit Universitas Diponegoro, 2014.

J. F. Hair, M. Sarstedt, C. M. Ringle, and J. A. Mena, “An assessment of the use of partial least squares structural equation modeling in marketing research,” J. Acad. Mark. Sci., vol. 40, no. 3, pp. 414–433, May 2012, doi: 10.1007/s11747-011-0261-6.

J. F. Hair, G. T. M. Hult, C. Ringle, and M. Sarstedt, “A Primer on Partial Least Squares Structural Equation Modeling (PLS-SEM) ,” Second eddition., Thousand Oaks: Sage, 2017.

J. Riou, H. Guyon, and B. Falissard, “An introduction to the partial least squares approach to structural equation modelling: a method for exploratory psychiatric research,” Int. J. Methods Psychiatr. Res., vol. 25, no. 3, pp. 220–231, 2016, doi: 10.1002/mpr.1497.

J. F. Hair, M. C. Howard, and C. Nitzl, “Assessing measurement model quality in PLS-SEM using confirmatory composite analysis,” J. Bus. Res., vol. 109, pp. 101–110, 2020, doi: 10.1016/j.jbusres.2019.11.069.

J. Henseler, G. Hubona, and P. A. Ray, “Using PLS path modeling in new technology research: Updated guidelines,” Ind. Manag. Data Syst., vol. 116, no. 1, pp. 2–20, 2016, doi: 10.1108/IMDS-09-2015-0382.

F. Ali, S. M. Rasoolimanesh, M. Sarstedt, C. M. Ringle, and K. Ryu, “An assessment of the use of partial least squares structural equation modeling (PLS-SEM) in hospitality research,” Int. J. Contemp. Hosp. Manag., vol. 30, no. 1, pp. 514–538, 2018, doi: 10.1108/IJCHM-10-2016-0568.

E. E. Rigdon, C. M. Ringle, and M. Sarstedt, “Structural modeling of heterogeneous data with partial least squares,” Rev. Mark. Res., vol. 7, pp. 255–296, 2010, doi: 10.1108/S1548-6435(2010)0000007011.

N. T. Brewer, G. B. Chapman, A. J. Rothman, J. Leask, and A. Kempe, “Increasing Vaccination: Putting Psychological Science Into Action,” Psychol. Sci. Public Interes., vol. 18, no. 3, pp. 149–207, 2017, doi: 10.1177/1529100618760521.

O. Isler, B. Isler, O. Kopsacheilis, and E. Ferguson, “Limits of the social-benefit motive among high-risk patients: A field experiment on influenza vaccination behaviour,” BMC Public Health, vol. 20, no. 1, p. 240, 2020, doi: 10.1186/s12889-020-8246-3.

M. A. Gerend and J. E. Shepherd, “Predicting human papillomavirus vaccine uptake in young adult women: Comparing the health belief model and theory of planned behavior,” Ann. Behav. Med., vol. 44, no. 2, pp. 171–180, 2012, doi: 10.1007/s12160-012-9366-5.

M. N. Sitaresmi, N. M. Rozanti, L. B. Simangunsong, and A. Wahab, “Improvement of Parent’s awareness, knowledge, perception, and acceptability of human papillomavirus vaccination after a structured-educational intervention,” BMC Public Health, vol. 20, no. 1, p. 1836, 2020, doi: 10.1186/s12889-020-09962-1.

A. L. Wagner et al., “Perceptions of measles, pneumonia, and meningitis vaccines among caregivers in Shanghai, China, and the health belief model: A cross-sectional study,” BMC Pediatr., vol. 17, no. 1, p. 143, 2017, doi: 10.1186/s12887-017-0900-2.

C. L. Jones, J. D. Jensen, C. L. Scherr, N. R. Brown, K. Christy, and J. Weaver, “The Health Belief Model as an Explanatory Framework in Communication Research: Exploring Parallel, Serial, and Moderated Mediation,” Health Commun., vol. 30, no. 6, pp. 566–576, 2015, doi: 10.1080/10410236.2013.873363.




DOI: http://doi.org/10.11591/ijphs.v10i4.20914

Refbacks

  • There are currently no refbacks.


International Journal of Public Health Science (IJPHS)
p-ISSN: 2252-8806, e-ISSN: 2620-4126

View IJPHS Stats

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.